( August 2, 2017, 11:42 AM EDT) -- TOKYO — Japanese drug maker Daiichi Sankyo Co. Ltd. on Aug. 1 agreed to pay up to $300 million to settle claims that the company’s blood pressure drug Benicar cause sprue-like enteropathy and other gastrointestinal conditions, according to a settlement agreement presented in the Benicar multidistrict litigation court (In Re: Benicar [Olmesartan] Products Liability Litigation, No. 15-2606, D. N.J.)....